1-5 of 5
Y Lam
Close
Sort by
Journal Articles

A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD + AML

Cheuk Him Man, Stephen S. Y. Lam, Murphy K. H. Sun, Howard C. H. Chow, Harinder Gill, Yok Lam Kwong, Anskar Y. H. Leung
Journal: Blood
Blood (2014) 123 (16): 2530–2539.
https://doi.org/10.1182/blood-2013-07-512194
Published: 2014
Includes: Supplemental data
Journal Articles

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors

Encouse B. Golden, Philip Y. Lam, Adel Kardosh, Kevin J. Gaffney, Enrique Cadenas, Stan G. Louie, Nicos A. Petasis, Thomas C. Chen, Axel H. Schönthal
Journal: Blood
Blood (2009) 113 (23): 5927–5937.
https://doi.org/10.1182/blood-2008-07-171389
Published: 2009
Journal Articles

In Vitro Evaluation of Apixaban, a Novel, Potent, Selective and Orally Bioavailable Factor Xa Inhibitor.

Joseph M. Luettgen, BS, Tracy A. Bozarth, MS, Jeffrey M. Bozarth, BS, Frank A. Barbera, BS, Patrick Y. Lam, PhD, Mimi L. Quan, PhD, Donald J. Pinto, PhD, Ruth R. Wexler, PhD, Alan R. Rendina, PhD, Robert M. Knabb, PhD
Journal: Blood
Blood (2006) 108 (11): 4130.
https://doi.org/10.1182/blood.V108.11.4130.4130
Published: 2006
Journal Articles

Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state

Brief Report
Gopesh Srivastava, Kai Y. Wong, Alan K. S. Chiang, King Y. Lam, Qian Tao
Journal: Blood
Blood (2000) 95 (7): 2443–2445.
https://doi.org/10.1182/blood.V95.7.2443
Published: 2000
Journal Articles

Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration

G Andreu, J Dewailly, C Leberre, MC Quarre, ML Bidet, R Tardivel, L Devers, Y Lam, E Soreau, C Boccaccio
Journal: Blood
Blood (1988) 72 (3): 964–969.
https://doi.org/10.1182/blood.V72.3.964.964
Published: 1988